Constellium Climbs Despite Q4 Loss

Constellium Climbs Despite Q4 Loss

Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC), Pendrell Corp. (NASDAQ:PCO) and Constellium NV (NYSE:CSTM) are making notable climbs this Thursday. EXCO Resources Inc. (NYSE:XCO), Lumos Networks Corp. (NASDAQ:LMOS) and Organovo Holdings Inc. (NYSEMKT:ONVO) are taking tumbles.

Sign up for our free newsletter

Dan Sundheim Founder Of D1 At Sohn 2021 On His Favorite Stock

Jeffrey Aronson Crossroads CapitalAt this year's Sohn Investment Conference, Dan Sundheim, the founder and CIO of D1 Capital Partners, spoke with John Collison, the co-founder of Stripe. Q1 2021 hedge fund letters, conferences and more D1 manages $20 billion. Of this, $10 billion is invested in fast-growing private businesses such as Stripe. Stripe is currently valued at around Read More


Pendrell Rebounds


Cyclacel Pharmaceuticals Inc. was up +12.83% about an hour and a half ahead of market close today. The stock – a Wilbur Ross holding – is still down more than -70% over the past year.

Pendrell Corporation gained +6.93% this Thursday, rebounding after hitting a new 52-week low just days ago. The intellectual property investment and advisory company, a Farallon Capital pick, is down -21% year-to-date.

Constellium NV surged +6.4% in the wake of its earnings report. The Netherlands-based company reported a fourth quarter loss of $18.1 million – something that apparently didn’t have Wall Street too nervous. George Soros has a stake in the firm, the share price of which has rallied about +22% in 2015.

EXCO Resources Plummets

EXCO Resources tumbled -9.94% today and looks weak on high trading volume. The company has had a rough to in recent weeks and in late February announced plans to cut its workforce by 15% and slash its capital budget by 35% in 2015. The billionaire taking a hit on this one: Wilbur Ross.

Lumos Networks dipped -7.09%, putting its five-day loss at about -10%. George Soros has a stake in the company.

Organovo Holdings fell -6.74% today and is down -40% YTD. Chase Coleman’s Tiger Global has a stake in the development-stage company.

Screen Shot 2015-02-23 at 3.00.26 PM


No posts to display